Friday, 25 July 2014
Last updated 18 hours ago
Jan 20 2011 | 2:59am ET
More than a dozen top medical research journals are to consider requiring authors to disclose payments from hedge funds and other investment firms.
The move by the New England Journal of Medicine, Journal of the American Medical Association, The Lancet and 11 other publications follows the arrest of a doctor for allegedly passing confidential information about a drug trial to hedge fund FrontPoint Partners. Yves Benhamou was an adviser to the drug market, Human Genome Sciences, as well as to several hedge funds.
The 14 members of the International Committee of Medical Journal Editors will discuss a possible disclosure requirement at their annual meeting in June. Researchers are already required to disclose financial relationships with drug and medical device makers.
Medical journals are scoured by health-care investors, and articles can have a major impact on the market.
Jul 8 2014 | 10:48am ET
The surge in derivatives regulation is among the most complex challenges facing the financial services industry today. Northern Trust’s Joshua Satten recently spoke with FINalternatives to share insights into the challenges presented by new regulation and explore how the industry is responding. Read more…